Neumora Therapeutics, Inc. (NMRA) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$241.16M | +8.5% |
| 2024 | -$263.46M | -4.5% |
| 2023 | -$252.10M | -85.5% |
| 2022 | -$135.87M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$241.16M | +8.5% |
| 2024 | -$263.46M | -4.5% |
| 2023 | -$252.10M | -85.5% |
| 2022 | -$135.87M | — |